Evaluation of real-world mobility in age-related macular degeneration

被引：0
|
作者：
Sabyasachi Sengupta
Angeline M Nguyen
Suzanne W van Landingham
Sharon D Solomon
Diana V Do
Luigi Ferrucci
David S Friedman
Pradeep Y Ramulu
机构：
[1] Johns Hopkins University,Wilmer Eye Institute
[2] University of Nebraska Medical Center,Truhlsen Eye Institute
[3] National Institute on Aging,The Longitudinal Studies Section, Clinical Research Branch
[4] National Institutes of Health,Dana Center for Preventive Ophthalmology
[5] Johns Hopkins Bloomberg School of Public Health,undefined
[6] Johns Hopkins University,undefined
来源：
BMC Ophthalmology | / 15卷
关键词：
Age-related macular degeneration; Physical activity; Mobility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [11] Real-World Weekly Efficacy Analysis of Faricimab in Patients with Age-Related Macular Degeneration
    Muth, Daniel R.
    Fasler, Katrin F.
    Kvanta, Anders
    Rejdak, Magdalena
    Blaser, Frank
    Zweifel, Sandrine A.
    BIOENGINEERING-BASEL, 2024, 11 (05):
  • [12] Consequences of Real-world Surveillance of Fellow Eyes in Neovascular Age-related Macular Degeneration
    Onwuka, Oluchukwu
    Saddemi, Jackson
    Akkan, F. Sema
    Lasalle, Claudia
    Ramsey, David J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [13] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [14] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [15] Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies
    Baumal, Caroline R.
    Sorensen, Torben Lykke
    Karcher, Helene
    Freitas, Rita L.
    Becher, Anja
    Balez, Sebastien
    Clemens, Andreas
    Singer, Michael
    Kodjikian, Laurent
    ACTA OPHTHALMOLOGICA, 2023, 101 (02) : 123 - 139
  • [16] Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study
    Chakraborty, Debdulal
    Maiti, Aniruddha
    Sheth, Jay U.
    Boral, Subhendu
    Mondal, Soumen
    Nandi, Krishnendu
    Sinha, Tushar
    Das, Arnab
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 3787 - 3795
  • [17] WET AGE-RELATED MACULAR DEGENERATION: TRENDS IN REAL-WORLD TREATMENT PATTERNS IN THE UNITED STATES
    Althoff, A. G.
    Rasouliyan, L.
    Kumar, V
    Long, S.
    Rao, M. B.
    VALUE IN HEALTH, 2022, 25 (12) : S277 - S277
  • [18] Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping review
    Gomez-Lumbreras, Ainhoa
    Ghule, Priyanka
    Panchal, Rupesh
    Giannouchos, Theodoros
    Lockhart, Catherine M.
    Brixner, Diana
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (12) : 4527 - 4539
  • [19] Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians
    Fenner, Beau J.
    Ting, Daniel S. W.
    Tan, Anna C. S.
    Teo, Kelvin
    Chan, Choi Mun
    Mathur, Ranjana
    Yeo, Ian Y. S.
    Wong, Tien Y.
    Wong, Edmund Y. M.
    Cheung, Chui Ming Gemmy
    OPHTHALMOLOGY RETINA, 2020, 4 (04): : 403 - 414
  • [20] Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
    Daien, Vincent
    Finger, Robert P.
    Talks, James S.
    Mitchell, Paul
    Wong, Tien Y.
    Sakamoto, Taiji
    Eldem, Bora M.
    Korobelnik, Jean-Francois
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (11) : 1475 - 1479
12345